These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 21394047)
1. Comparison of PET-CT images with the histopathological picture of a resectable primary tumor for delineating GTV in nonsmall cell lung cancer. Lin S; Han B; Yu L; Shan D; Wang R; Ning X Nucl Med Commun; 2011 Jun; 32(6):479-85. PubMed ID: 21394047 [TBL] [Abstract][Full Text] [Related]
2. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer. Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410 [TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? Biehl KJ; Kong FM; Dehdashti F; Jin JY; Mutic S; El Naqa I; Siegel BA; Bradley JD J Nucl Med; 2006 Nov; 47(11):1808-12. PubMed ID: 17079814 [TBL] [Abstract][Full Text] [Related]
4. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572 [TBL] [Abstract][Full Text] [Related]
5. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. van Baardwijk A; Bosmans G; Boersma L; Buijsen J; Wanders S; Hochstenbag M; van Suylen RJ; Dekker A; Dehing-Oberije C; Houben R; Bentzen SM; van Kroonenburgh M; Lambin P; De Ruysscher D Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):771-8. PubMed ID: 17398018 [TBL] [Abstract][Full Text] [Related]
6. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906 [TBL] [Abstract][Full Text] [Related]
7. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results. Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer. Yu HM; Liu YF; Hou M; Liu J; Li XN; Yu JM Eur J Radiol; 2009 Oct; 72(1):104-13. PubMed ID: 18640802 [TBL] [Abstract][Full Text] [Related]
9. A follow-up of integrated positron emission tomography/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients. Cho S; Lee EB J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1447-51. PubMed ID: 20005529 [TBL] [Abstract][Full Text] [Related]
10. FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation. Shim SS; Han J Ann Nucl Med; 2010 Jun; 24(5):357-62. PubMed ID: 20306161 [TBL] [Abstract][Full Text] [Related]
11. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer. Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978 [TBL] [Abstract][Full Text] [Related]
12. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135 [TBL] [Abstract][Full Text] [Related]
13. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Cerfolio RJ; Ojha B; Bryant AS; Raghuveer V; Mountz JM; Bartolucci AA Ann Thorac Surg; 2004 Sep; 78(3):1017-23; discussion 1017-23. PubMed ID: 15337041 [TBL] [Abstract][Full Text] [Related]
14. STIR turbo SE MR imaging vs. coregistered FDG-PET/CT: quantitative and qualitative assessment of N-stage in non-small-cell lung cancer patients. Ohno Y; Koyama H; Nogami M; Takenaka D; Yoshikawa T; Yoshimura M; Ohbayashi C; Sugimura K J Magn Reson Imaging; 2007 Oct; 26(4):1071-80. PubMed ID: 17896365 [TBL] [Abstract][Full Text] [Related]
20. [Use of positron emission tomography in assessing hidden extrathoracic metastasis in non small cell lung cancer]. Alonso Moralejo R; Sayas Catalán J; García Luján R; Coronado Poggio M; Monsó Molas E; López Encuentra A Arch Bronconeumol; 2010 May; 46(5):238-43. PubMed ID: 20378233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]